Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. Yet their therapeutic promise has long been undermined by a practical problem: most ingested bacteria die before they ever reach the intestine. Stomach acid, bile salts and digestive enzymes decimate unprotected cells, and even the survivors often pass through the gut without adhering to the mucosal surface, limiting the time they have to interact with the intestinal wall. In recent years, scientists have come to appreciate that some of the health effects attributed to probiotics may actually be mediated not by the bacteria themselves but by the extracellular vesicles they release. These nanoscale lipid bubbles, typically 70 to 100 nanometers in diameter, carry proteins and other signaling molecules deep into the mucus layer and can modulate immune responses without involving live cells.

The research team, led by Cecilia L. D’Antoni and Oscar E. Pérez at the University of Buenos Aires and CONICET, set out to solve both problems simultaneously with a single delivery vehicle. They selected Lacticaseibacillus casei BL23, a well-characterized probiotic strain, and encapsulated it in a matrix built from two food-grade ingredients: whey protein isolate, a byproduct of cheese manufacturing, and chitosan, a natural polysaccharide derived from shellfish shells. Whey proteins form a protective gel-like layer around the cells, while chitosan is positively charged at intestinal pH, allowing it to bind electrostatically to the negatively charged mucus glycoproteins that line the gut. The result is a mucoadhesive shell that anchors the capsules to the intestinal surface instead of letting them wash through.

Getting the recipe right was far from trivial. The researchers used a statistical optimization approach known as central composite design to systematically vary the concentrations of whey protein isolate and chitosan and identify the formulation that best balanced several competing demands. Too much chitosan can be antimicrobial, harming the very bacteria the capsule is meant to protect; too little fails to confer mucoadhesion. The winner was a formulation containing 20 percent whey protein isolate and 0.5 percent chitosan, processed by spray drying. In this technique, a liquid suspension of bacteria and wall materials is atomized into a hot drying chamber, where droplets instantly lose their water and harden into particles. The resulting microcapsules were predominantly spherical and measured between 2 and 15 micrometers, a size range well suited to food applications.

The encapsulated bacteria emerged from the process with viable counts of 6.6 × 10⁹ colony-forming units per gram, comfortably within the ranges recommended for probiotic products. More importantly, the capsules proved extraordinarily sticky. In laboratory assays, the chitosan-containing formulation showed approximately 77 times greater mucoadhesion than capsules made of whey protein alone, a dramatic enhancement attributable to the electrostatic attraction between the cationic polysaccharide and anionic mucins. Greater adhesion means longer residence time at the intestinal interface, which in turn increases the window during which the encapsulated bacteria can proliferate, secrete their bioactive molecules and interact with the host.

Protection during gastrointestinal transit was equally impressive. When the researchers subjected both free and encapsulated bacteria to a simulated digestive journey, beginning with a gastric phase of low pH and pepsin followed by intestinal conditions, the difference was stark. Free bacteria suffered a loss of roughly 6 logarithmic units, the equivalent of a 99.9999 percent kill rate. Encapsulated bacteria lost only about 2 log units, meaning roughly 100 times more cells survived. For a supplement or functional food, that difference could determine whether a product delivers a meaningful dose of live culture to the intestine or essentially nothing at all.

The capsules also preserved what food scientists call fermentative capacity, the ability of the bacteria to ferment lactose and acidify milk. When reconstituted into milk, bacteria released from the capsules performed indistinguishably from never-encapsulated controls, and the resulting fermented products showed reduced syneresis, the unsightly separation of whey from the gel that plagues many commercial yogurts. That observation hints at a secondary commercial benefit: encapsulated cultures may produce structurally more stable fermented foods. Storage stability was confirmed at both 4 degrees Celsius and minus 20 degrees Celsius, covering the cold chain conditions typical of dairy products and frozen concentrates.

The study’s most novel claim, however, concerns the extracellular vesicles. Vesicle secretion is an active, energy-dependent process performed by living bacteria, and a harsh encapsulation procedure could plausibly damage the machinery responsible. The team demonstrated that it does not. Bacteria recovered from the microcapsules continued to secrete vesicles in the characteristic 70-to-100-nanometer range, and proteomic analysis showed these vesicles were enriched in p40 and p75, two well-studied proteins produced by L. casei that are associated with anti-inflammatory effects and intestinal epithelial protection. In other words, the capsules function not merely as a passive shield but as an in-situ bioreactor, delivering living, vesicle-secreting bacteria directly to the site where those vesicles are most likely to do good.

This dual capability, live bacteria plus preserved postbiotic secretion, matters because the two modes of action are complementary. Live cells can colonize the mucus layer and sustain production of beneficial molecules over time, while the vesicles themselves can diffuse into mucus and interact with host tissues even where live cells cannot penetrate. Previous work on extracellular vesicles as therapeutics has been hampered by delivery problems of its own: free vesicles administered orally face rapid degradation and poor targeting. By keeping the production line intact inside a mucoadhesive capsule, the new system effectively factories the vesicles at the intestinal wall, sidestepping the need to formulate and stabilize the vesicles separately.

The work, performed with institutional support from CONICET and Argentina’s national research agency and published as an open-access article, positions whey protein–chitosan microcapsules as a robust strategy for targeted delivery of postbiotic extracellular vesicles in nutraceutical and functional food development. Because both wall materials are inexpensive, food-grade and widely available, the formulation is amenable to industrial translation. The authors note that further studies will be needed to confirm the findings in animal models and humans, and to establish how long the encapsulated bacteria remain resident and productive in a living gut. But as a proof of principle, the study makes a compelling case that the next generation of probiotic products may deliver their benefits through tiny spherical couriers, 2 to 15 micrometers wide, engineered to stick, survive and secrete.

A comprehensive exploration into Saskatoon berry reveals that its nutritional composition is exceptionally rich and multifaceted. The berry houses an impressive array of macro- and micronutrients, including essential vitamins such as vitamin C and a spectrum of B vitamins, as well as minerals like potassium, calcium, and magnesium. These components contribute fundamentally to the berry’s role as a functional food ingredient, providing not only sustenance but also significant bioactive compounds that underpin its distinct health benefits.

From a phytochemical perspective, Saskatoon berry is a powerhouse of antioxidants and phenolic compounds. These bioactive molecules, including anthocyanins, flavonoids, and phenolic acids, are pivotal in mitigating oxidative stress, a primary contributor to cellular aging and chronic diseases. The berry’s vibrant coloration is attributed to its high anthocyanin content, which offers potent free radical scavenging capabilities, thereby positioning Saskatoon berries as a critical player in the prevention and management of oxidative stress-related conditions.

Scientific investigations have demonstrated that regular consumption of Saskatoon berries can have a positive impact on cardiovascular health. The berry’s rich phytochemical profile facilitates the reduction of low-density lipoprotein (LDL) cholesterol oxidation, improving endothelial function and reducing the risk of atherosclerosis. Furthermore, these health benefits are further enhanced by the anti-inflammatory effects inherent to the berry’s phenolic compounds, which act to modulate inflammatory pathways linked to heart disease.

Moreover, the Saskatoon berry has shown promising neuroprotective properties. Emerging evidence suggests that its antioxidants can penetrate the blood-brain barrier, offering neuroinflammation mitigation and cognitive function enhancement. This opens a new frontier in the potential utilization of the berry in preventing or slowing the progression of neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, which afflict millions globally.

Another groundbreaking aspect of Saskatoon berry research is its influence on glycemic control and metabolic health. Studies tracking the berry’s impact on glucose tolerance have revealed significant improvements in insulin sensitivity, making it a favorable dietary supplement for individuals with metabolic syndrome or type 2 diabetes. The berry’s low glycemic index combined with its fiber content contributes to moderated postprandial blood sugar levels, which is critical for managing diabetes and preventing complications.

The question of shelf-life extension has become increasingly pertinent in the food industry, especially considering the demand for natural preservatives. Saskatoon berry extracts have displayed antimicrobial and antioxidant properties that can be harnessed to prolong the freshness and safety of perishable foods. This novel application could revolutionize food preservation by reducing reliance on synthetic additives and extending the usability of fruits, vegetables, and dairy products.

Research has also expanded into the functional utilization of Saskatoon berries in diverse gastronomic and industrial contexts. The berry’s flavor profile, which combines subtle sweetness with tart undertones, makes it an attractive ingredient for jams, jellies, beverages, and baked goods. Beyond culinary uses, its phytochemicals are being isolated for incorporation into dietary supplements and cosmeceuticals, where they can provide skin health benefits and combat oxidative stress-induced skin aging.

To further capitalize on these benefits, studies are investigating advanced agricultural techniques and post-harvest interventions to optimize berry yield and phytochemical content. Controlled environment agriculture, selective breeding, and organic farming are among the strategies being assessed to maximize the nutraceutical properties of Saskatoon berries while maintaining ecological sustainability.

The comprehensive utilization of Saskatoon berry aligns synergistically with global trends emphasizing natural health products and sustainable food systems. Its raw nutritional and phytochemical attributes, combined with promising applications in disease prevention and food preservation, positions the berry as a multifaceted ingredient capable of bridging the gap between traditional nutrition and cutting-edge biotechnology.

On an analytical level, advanced chromatographic and spectrometric methods have been employed to profile the berry’s complex phytochemical spectrum. These analyses have not only identified known antioxidants but have also uncovered unique compounds that could serve as novel biomarkers for quality control and health efficacy assessments in functional food formulations.

Meanwhile, clinical trials assessing the bioavailability and metabolic impact of Saskatoon berry bioactives provide critical insight into dosage, efficacy, and safety. These studies suggest that incorporating even moderate amounts of berries into daily dietary regimens can yield measurable health improvements without adverse effects, enhancing the berry’s appeal to health-conscious consumers.

The implications for public health nutrition are profound, considering the increasing burden of chronic illness driven by oxidative stress, inflammation, and metabolic dysregulation. Saskatoon berry-based interventions hold promise for preventive health strategies aimed at reducing the incidence of cardiovascular diseases, neurodegenerative disorders, and metabolic imbalances at the population level.

It is noteworthy that commercialization efforts are gaining momentum, with startups and established food companies exploring innovative Saskatoon berry products ranging from functional beverages to nutraceutical capsules. This industrial interest is underpinned by growing consumer demand for natural, nutrient-dense food options that support holistic wellness.

In conclusion, the Saskatoon berry stands at a fascinating intersection of tradition, science, and innovation. Its robust nutritional and phytochemical composition, coupled with empirically validated health benefits and potential for shelf-life extension, spearheads a new era in food science and biotechnology. Continued research and development are paramount to unlocking the berry’s full potential, fostering its integration into mainstream diets and health interventions globally.

Subject of Research: The nutritional composition, phytochemical properties, health benefits, shelf-life extension capabilities, and utilization of Saskatoon berry (Amelanchier alnifolia).

Article Title: Saskatoon berry (Amelanchier alnifolia): nutritional composition, phytochemical, health benefits, shelf-life extension and utilization.

Article References:
Li, D., Cheng, Z., Wan Ibadullah, W.Z. et al. Saskatoon berry (Amelanchier alnifolia): nutritional composition, phytochemical, health benefits, shelf-life extension and utilization. Food Sci Biotechnol (2025). https://doi.org/10.1007/s10068-025-01997-7

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s10068-025-01997-7